Girman kasuwa na dermal fillers a cikin 2020 zai wuce dalar Amurka biliyan 6.5, kuma ana sa ran haɓakar haɓakar shekara-shekara zai wuce 7.8% daga 2020 zuwa 2028. Ci gaba da ci gaban filler, kamar amfani da kayan da canje-canje a cikin sakamakon tsayin daka. , kwanan nan gaba ɗaya sun canza yanayin ɗaukar filler dermal.
Filler dermal samfurin ne da aka yi masa allura ko sanya shi a cikin fata don taimakawa rage layin fuska da dawo da girma da cikar fuska.Ana sa ran cewa yayin lokacin hasashen, haɓaka hankali ga sha'awar ƙaya zai haifar da haɓakar kasuwar filler ta duniya.Misali, bisa ga wani bincike da GlobalData ta gudanar a shekarar 2018, kusan kashi uku cikin hudu na mazajen Koriya suna fuskantar kyawu ko kuma kayan kwalliya a kalla sau daya a mako.
Samun damar bincike mai zurfi akan kasuwar filler!Danna nan don samun nazarin samfurin kasuwa na PDF kyauta @ https://www.stratagemmarketinsights.com/sample/37935
Ana sa ran karuwar yawan tsofaffi zai samar da damar ci gaba mai riba ga mahalarta a cikin kasuwar filler ta duniya.Misali, a cewar Hukumar Lafiya ta Duniya, nan da shekara ta 2050, ana sa ran yawan tsofaffi zai kai biliyan 2, sama da miliyan 900 a shekarar 2015. Bugu da kari, ana sa ran babban ci gaban yawon shakatawa na likitanci a cikin kasashe masu tasowa, kuma ana sa ran zai taimaka wajen bunkasa kasuwa. .Misali, bisa ga bayanan da Gidauniyar Samar da daidaito ta Indiya ta fitar a cikin Janairu 2019, adadin masu yawon bude ido na kasashen waje na Indiya (FTA) don dalilai na kiwon lafiya a cikin 2015, 2016 da 2017 an kiyasta su 2,33,918, 4,27,014 da 4, bi da bi.95,056 mutum-lokaci.
Galderma Pharma SA, Sinclair Pharma plc., Allergan Plc., Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Adoderm GmbH da Laboratoires Vivacy SAS.
Kasuwar ta shaida karuwar fifikon maza don maganin kwaskwarima ba na tiyata ba.Misali, a cikin Yuni 2019, RealSelf, wata hanya ta kan layi don koyo game da hanyoyin kwaskwarima da tuntuɓar likitocin da ke ba da waɗannan hanyoyin, ya ruwaito cewa idan aka kwatanta da 2028, adadin mazan da ke nazarin magungunan kwaskwarima ba na tiyata ya karu da 6% a cikin 2021.
Amurka za ta jagoranci kasuwar duniya a lokacin annabta.Dangane da rahoton kasuwar filler dermal wanda MRFR ya tattara, ana tsammanin Amurka za ta sami mafi girman kason kasuwa yayin lokacin bincike.Ana iya danganta haɓakar kasuwannin yanki ga karuwar buƙatun kayan kwalliya da karuwar buƙatar tiyatar fuska kaɗan.Bugu da kari, karuwar sabbin gwaje-gwajen asibiti na fata da kayan kwalliya na iya kara inganta ci gaban kasuwar yankin.A cikin dukkan kasashen yankin, ana sa ran Amurka za ta bayar da gagarumar gudunmawa wajen bunkasa kasuwannin yankin.
Lokacin aikawa: Agusta-27-2021